Product | Modality | Indication | Target | Lead | Candidate | Preclin. | Phase I | Partner | Grant |
AMB302 | ADC | GBM, bladder | FGFR3 | ![]() |
![]() |
||||
AMB001 | mAb | Atopic dermatitis & dementia |
CD200R1 | ![]() |
|||||
AMB018 | BsAb | Solid tumors | ![]() |
||||||
AMB501 | CAR-NK | Solid tumors | ![]() |
||||||
AMB015 | ADC | Hematologic & solid tumors |
Undisclosed | ||||||
AMB020 | Small molecule |
GBM | Undisclosed | ||||||
AMB011 | BsAb | CNS |
Product | Tech | Indication | Class | PoC | L/O | Partner | Grant |
AMB401 | Payload | Solid tumors | Duocarmycin | Undisclosed | |||
AMB402 | Payload | Solid tumors | |||||
AMB008 | BBB penetration |
Brain diseases |
Product | Modality | Development Status |
---|---|---|
AMB302 | ADC | Pre-Clinical |
Indication | ||
Bladder cancer, GBM, solid tumors |
An FGFR3 targeting ADC program that utilizes AIMEDBIO’s proprietary antibody to target FGFR3 overexpressing solid tumors and glioblastomas with FGFR3-TACC3 fusion.
Product | Modality | Development Status |
---|---|---|
AMB001 | mAb | Pre-Clinical |
Indication | ||
Atopic dermatitis, dementia |
An anti-CD200R1 monoclonal antibody which regulates immune checkpoint through agonistic effect.
Product | Modality | Development Status |
---|---|---|
AMB018 | BsAb | Candidate selection |
Indication | ||
Solid tumor |
Product | Modality | Development Status |
---|---|---|
AMB501 | CAR-NK | Candidate selection |
Indication | ||
Solid tumor |
Product | Modality | Development Status |
---|---|---|
AMB015 | ADC | Candidate selection |
Indication | Partner | |
Hematologic & solid tumor | Undisclosed |
Product | Modality | Development Status |
---|---|---|
AMB020 | Small molecule | Candidate selection |
Indication | Partner | |
GBM | Undisclosed |
Product | Modality | Development Status |
---|---|---|
AMB011 | BsAb | Candidate selection |
Indication | ||
CNS |
Product | Modality | Indication |
---|---|---|
AMB401 | Payload | PoC |
Indication | Class | Partner |
Solid tumors | Duocarmycin | Undisclosed |
Product | Modality | Indication |
---|---|---|
AMB402 | Payload | PoC |
Indication | ||
Solid tumors |
Product | Modality | Indication |
---|---|---|
AMB008 | BBB penetration | PoC |
Indication | ||
Solid tumors |